nodes	percent_of_prediction	percent_of_DWPC	metapath
Timolol—CYP2C19—Teniposide—lymphatic system cancer	0.165	0.457	CbGbCtD
Timolol—ABCB1—Mitoxantrone—lymphatic system cancer	0.0931	0.258	CbGbCtD
Timolol—ABCB1—Vincristine—lymphatic system cancer	0.0641	0.177	CbGbCtD
Timolol—ABCB1—Methotrexate—lymphatic system cancer	0.0388	0.107	CbGbCtD
Timolol—Abdominal pain—Teniposide—lymphatic system cancer	0.00178	0.00278	CcSEcCtD
Timolol—Body temperature increased—Teniposide—lymphatic system cancer	0.00178	0.00278	CcSEcCtD
Timolol—Erythema—Bleomycin—lymphatic system cancer	0.00178	0.00278	CcSEcCtD
Timolol—Paraesthesia—Fludarabine—lymphatic system cancer	0.00178	0.00278	CcSEcCtD
Timolol—Hallucination—Carmustine—lymphatic system cancer	0.00177	0.00277	CcSEcCtD
Timolol—Sweating—Mitoxantrone—lymphatic system cancer	0.00177	0.00277	CcSEcCtD
Timolol—Dyspnoea—Fludarabine—lymphatic system cancer	0.00176	0.00276	CcSEcCtD
Timolol—Oedema peripheral—Carmustine—lymphatic system cancer	0.00175	0.00275	CcSEcCtD
Timolol—Connective tissue disorder—Carmustine—lymphatic system cancer	0.00175	0.00274	CcSEcCtD
Timolol—Dyspepsia—Fludarabine—lymphatic system cancer	0.00174	0.00272	CcSEcCtD
Timolol—Sinusitis—Mitoxantrone—lymphatic system cancer	0.00173	0.00271	CcSEcCtD
Timolol—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00172	0.00269	CcSEcCtD
Timolol—Decreased appetite—Fludarabine—lymphatic system cancer	0.00172	0.00269	CcSEcCtD
Timolol—Visual impairment—Carmustine—lymphatic system cancer	0.00172	0.00269	CcSEcCtD
Timolol—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00171	0.00267	CcSEcCtD
Timolol—Fatigue—Fludarabine—lymphatic system cancer	0.0017	0.00267	CcSEcCtD
Timolol—Hallucination—Vincristine—lymphatic system cancer	0.00169	0.00265	CcSEcCtD
Timolol—Pain—Fludarabine—lymphatic system cancer	0.00169	0.00265	CcSEcCtD
Timolol—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00169	0.00264	CcSEcCtD
Timolol—Respiratory failure—Methotrexate—lymphatic system cancer	0.00167	0.00262	CcSEcCtD
Timolol—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00167	0.00262	CcSEcCtD
Timolol—Eye disorder—Carmustine—lymphatic system cancer	0.00166	0.00261	CcSEcCtD
Timolol—Rhinitis—Mitoxantrone—lymphatic system cancer	0.00166	0.0026	CcSEcCtD
Timolol—Hypersensitivity—Teniposide—lymphatic system cancer	0.00166	0.00259	CcSEcCtD
Timolol—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00163	0.00255	CcSEcCtD
Timolol—Asthenia—Teniposide—lymphatic system cancer	0.00161	0.00253	CcSEcCtD
Timolol—Pruritus—Teniposide—lymphatic system cancer	0.00159	0.00249	CcSEcCtD
Timolol—Arrhythmia—Carmustine—lymphatic system cancer	0.00159	0.00249	CcSEcCtD
Timolol—Cardiac disorder—Vincristine—lymphatic system cancer	0.00158	0.00247	CcSEcCtD
Timolol—Alopecia—Carmustine—lymphatic system cancer	0.00157	0.00246	CcSEcCtD
Timolol—Body temperature increased—Fludarabine—lymphatic system cancer	0.00156	0.00245	CcSEcCtD
Timolol—Mental disorder—Carmustine—lymphatic system cancer	0.00156	0.00244	CcSEcCtD
Timolol—Malnutrition—Carmustine—lymphatic system cancer	0.00155	0.00243	CcSEcCtD
Timolol—Erythema—Carmustine—lymphatic system cancer	0.00155	0.00243	CcSEcCtD
Timolol—Cough—Bleomycin—lymphatic system cancer	0.00155	0.00243	CcSEcCtD
Timolol—Angiopathy—Vincristine—lymphatic system cancer	0.00154	0.00241	CcSEcCtD
Timolol—Diarrhoea—Teniposide—lymphatic system cancer	0.00154	0.00241	CcSEcCtD
Timolol—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00153	0.0024	CcSEcCtD
Timolol—Chest pain—Bleomycin—lymphatic system cancer	0.00151	0.00237	CcSEcCtD
Timolol—Myalgia—Bleomycin—lymphatic system cancer	0.00151	0.00237	CcSEcCtD
Timolol—Alopecia—Vincristine—lymphatic system cancer	0.0015	0.00235	CcSEcCtD
Timolol—Discomfort—Bleomycin—lymphatic system cancer	0.00149	0.00234	CcSEcCtD
Timolol—Mental disorder—Vincristine—lymphatic system cancer	0.00149	0.00233	CcSEcCtD
Timolol—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00148	0.00232	CcSEcCtD
Timolol—Alopecia—Mitoxantrone—lymphatic system cancer	0.00146	0.00229	CcSEcCtD
Timolol—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.00146	0.00229	CcSEcCtD
Timolol—Confusional state—Bleomycin—lymphatic system cancer	0.00146	0.00229	CcSEcCtD
Timolol—Vision blurred—Carmustine—lymphatic system cancer	0.00146	0.00229	CcSEcCtD
Timolol—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00146	0.00228	CcSEcCtD
Timolol—Oedema—Bleomycin—lymphatic system cancer	0.00145	0.00227	CcSEcCtD
Timolol—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00145	0.00227	CcSEcCtD
Timolol—Erythema—Mitoxantrone—lymphatic system cancer	0.00144	0.00226	CcSEcCtD
Timolol—Infection—Bleomycin—lymphatic system cancer	0.00144	0.00225	CcSEcCtD
Timolol—Vomiting—Teniposide—lymphatic system cancer	0.00143	0.00224	CcSEcCtD
Timolol—Asthenia—Fludarabine—lymphatic system cancer	0.00142	0.00222	CcSEcCtD
Timolol—Rash—Teniposide—lymphatic system cancer	0.00142	0.00222	CcSEcCtD
Timolol—Dermatitis—Teniposide—lymphatic system cancer	0.00142	0.00222	CcSEcCtD
Timolol—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00141	0.00221	CcSEcCtD
Timolol—Headache—Teniposide—lymphatic system cancer	0.00141	0.00221	CcSEcCtD
Timolol—Pruritus—Fludarabine—lymphatic system cancer	0.0014	0.00219	CcSEcCtD
Timolol—Anorexia—Bleomycin—lymphatic system cancer	0.00138	0.00216	CcSEcCtD
Timolol—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00136	0.00213	CcSEcCtD
Timolol—Hypotension—Bleomycin—lymphatic system cancer	0.00135	0.00212	CcSEcCtD
Timolol—Diarrhoea—Fludarabine—lymphatic system cancer	0.00135	0.00212	CcSEcCtD
Timolol—Hypertension—Carmustine—lymphatic system cancer	0.00134	0.0021	CcSEcCtD
Timolol—Nausea—Teniposide—lymphatic system cancer	0.00134	0.00209	CcSEcCtD
Timolol—Vertigo—Vincristine—lymphatic system cancer	0.00133	0.00208	CcSEcCtD
Timolol—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00132	0.00207	CcSEcCtD
Timolol—Chest pain—Carmustine—lymphatic system cancer	0.00132	0.00207	CcSEcCtD
Timolol—Myalgia—Carmustine—lymphatic system cancer	0.00132	0.00207	CcSEcCtD
Timolol—Anxiety—Carmustine—lymphatic system cancer	0.00132	0.00206	CcSEcCtD
Timolol—Paraesthesia—Bleomycin—lymphatic system cancer	0.0013	0.00204	CcSEcCtD
Timolol—Dyspnoea—Bleomycin—lymphatic system cancer	0.00129	0.00202	CcSEcCtD
Timolol—Hypertension—Vincristine—lymphatic system cancer	0.00128	0.002	CcSEcCtD
Timolol—Confusional state—Carmustine—lymphatic system cancer	0.00128	0.002	CcSEcCtD
Timolol—Oedema—Carmustine—lymphatic system cancer	0.00127	0.00198	CcSEcCtD
Timolol—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.00126	0.00198	CcSEcCtD
Timolol—Decreased appetite—Bleomycin—lymphatic system cancer	0.00126	0.00197	CcSEcCtD
Timolol—Myalgia—Vincristine—lymphatic system cancer	0.00126	0.00197	CcSEcCtD
Timolol—Visual disturbance—Methotrexate—lymphatic system cancer	0.00126	0.00197	CcSEcCtD
Timolol—Cough—Mitoxantrone—lymphatic system cancer	0.00126	0.00197	CcSEcCtD
Timolol—Infection—Carmustine—lymphatic system cancer	0.00126	0.00197	CcSEcCtD
Timolol—Vomiting—Fludarabine—lymphatic system cancer	0.00126	0.00197	CcSEcCtD
Timolol—Rash—Fludarabine—lymphatic system cancer	0.00125	0.00195	CcSEcCtD
Timolol—Dermatitis—Fludarabine—lymphatic system cancer	0.00125	0.00195	CcSEcCtD
Timolol—Hypertension—Mitoxantrone—lymphatic system cancer	0.00124	0.00195	CcSEcCtD
Timolol—Pain—Bleomycin—lymphatic system cancer	0.00124	0.00194	CcSEcCtD
Timolol—Headache—Fludarabine—lymphatic system cancer	0.00124	0.00194	CcSEcCtD
Timolol—Chest pain—Mitoxantrone—lymphatic system cancer	0.00123	0.00192	CcSEcCtD
Timolol—Myalgia—Mitoxantrone—lymphatic system cancer	0.00123	0.00192	CcSEcCtD
Timolol—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00123	0.00192	CcSEcCtD
Timolol—Anxiety—Mitoxantrone—lymphatic system cancer	0.00122	0.00191	CcSEcCtD
Timolol—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.00122	0.0019	CcSEcCtD
Timolol—Discomfort—Mitoxantrone—lymphatic system cancer	0.00121	0.0019	CcSEcCtD
Timolol—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00121	0.00189	CcSEcCtD
Timolol—Oedema—Vincristine—lymphatic system cancer	0.00121	0.00189	CcSEcCtD
Timolol—Anorexia—Carmustine—lymphatic system cancer	0.00121	0.00189	CcSEcCtD
Timolol—Infection—Vincristine—lymphatic system cancer	0.0012	0.00188	CcSEcCtD
Timolol—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00119	0.00187	CcSEcCtD
Timolol—Osteoarthritis—Methotrexate—lymphatic system cancer	0.00119	0.00187	CcSEcCtD
Timolol—Confusional state—Mitoxantrone—lymphatic system cancer	0.00119	0.00186	CcSEcCtD
Timolol—Nervous system disorder—Vincristine—lymphatic system cancer	0.00118	0.00185	CcSEcCtD
Timolol—Hypotension—Carmustine—lymphatic system cancer	0.00118	0.00185	CcSEcCtD
Timolol—Oedema—Mitoxantrone—lymphatic system cancer	0.00118	0.00184	CcSEcCtD
Timolol—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00118	0.00184	CcSEcCtD
Timolol—Nausea—Fludarabine—lymphatic system cancer	0.00117	0.00184	CcSEcCtD
Timolol—Infection—Mitoxantrone—lymphatic system cancer	0.00117	0.00183	CcSEcCtD
Timolol—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00117	0.00183	CcSEcCtD
Timolol—Shock—Mitoxantrone—lymphatic system cancer	0.00116	0.00181	CcSEcCtD
Timolol—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00115	0.0018	CcSEcCtD
Timolol—Urticaria—Bleomycin—lymphatic system cancer	0.00115	0.0018	CcSEcCtD
Timolol—Anorexia—Vincristine—lymphatic system cancer	0.00115	0.0018	CcSEcCtD
Timolol—Body temperature increased—Bleomycin—lymphatic system cancer	0.00115	0.00179	CcSEcCtD
Timolol—Insomnia—Carmustine—lymphatic system cancer	0.00114	0.00179	CcSEcCtD
Timolol—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00114	0.00179	CcSEcCtD
Timolol—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00114	0.00178	CcSEcCtD
Timolol—Paraesthesia—Carmustine—lymphatic system cancer	0.00114	0.00178	CcSEcCtD
Timolol—Mood swings—Methotrexate—lymphatic system cancer	0.00113	0.00177	CcSEcCtD
Timolol—Hypotension—Vincristine—lymphatic system cancer	0.00113	0.00177	CcSEcCtD
Timolol—Dyspnoea—Carmustine—lymphatic system cancer	0.00113	0.00177	CcSEcCtD
Timolol—Somnolence—Carmustine—lymphatic system cancer	0.00112	0.00176	CcSEcCtD
Timolol—Anorexia—Mitoxantrone—lymphatic system cancer	0.00112	0.00176	CcSEcCtD
Timolol—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.0011	0.00172	CcSEcCtD
Timolol—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.0011	0.00172	CcSEcCtD
Timolol—Decreased appetite—Carmustine—lymphatic system cancer	0.0011	0.00172	CcSEcCtD
Timolol—Hypotension—Mitoxantrone—lymphatic system cancer	0.0011	0.00172	CcSEcCtD
Timolol—Insomnia—Vincristine—lymphatic system cancer	0.00109	0.00171	CcSEcCtD
Timolol—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00109	0.00171	CcSEcCtD
Timolol—Paraesthesia—Vincristine—lymphatic system cancer	0.00108	0.0017	CcSEcCtD
Timolol—Pain—Carmustine—lymphatic system cancer	0.00108	0.00169	CcSEcCtD
Timolol—Breast disorder—Methotrexate—lymphatic system cancer	0.00108	0.00169	CcSEcCtD
Timolol—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00107	0.00168	CcSEcCtD
Timolol—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00107	0.00167	CcSEcCtD
Timolol—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00106	0.00165	CcSEcCtD
Timolol—Decreased appetite—Vincristine—lymphatic system cancer	0.00105	0.00164	CcSEcCtD
Timolol—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00105	0.00164	CcSEcCtD
Timolol—Somnolence—Mitoxantrone—lymphatic system cancer	0.00105	0.00164	CcSEcCtD
Timolol—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00104	0.00163	CcSEcCtD
Timolol—Feeling abnormal—Carmustine—lymphatic system cancer	0.00104	0.00163	CcSEcCtD
Timolol—Fatigue—Vincristine—lymphatic system cancer	0.00104	0.00163	CcSEcCtD
Timolol—Asthenia—Bleomycin—lymphatic system cancer	0.00104	0.00163	CcSEcCtD
Timolol—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00104	0.00162	CcSEcCtD
Timolol—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00103	0.00162	CcSEcCtD
Timolol—Pain—Vincristine—lymphatic system cancer	0.00103	0.00162	CcSEcCtD
Timolol—Asthma—Methotrexate—lymphatic system cancer	0.00103	0.00161	CcSEcCtD
Timolol—Pruritus—Bleomycin—lymphatic system cancer	0.00103	0.00161	CcSEcCtD
Timolol—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00102	0.0016	CcSEcCtD
Timolol—Fatigue—Mitoxantrone—lymphatic system cancer	0.00101	0.00159	CcSEcCtD
Timolol—Pain—Mitoxantrone—lymphatic system cancer	0.00101	0.00157	CcSEcCtD
Timolol—Body temperature increased—Carmustine—lymphatic system cancer	0.001	0.00157	CcSEcCtD
Timolol—Abdominal pain—Carmustine—lymphatic system cancer	0.001	0.00157	CcSEcCtD
Timolol—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000988	0.00155	CcSEcCtD
Timolol—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000969	0.00152	CcSEcCtD
Timolol—Dysuria—Methotrexate—lymphatic system cancer	0.000964	0.00151	CcSEcCtD
Timolol—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000962	0.00151	CcSEcCtD
Timolol—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000958	0.0015	CcSEcCtD
Timolol—Abdominal pain—Vincristine—lymphatic system cancer	0.000955	0.00149	CcSEcCtD
Timolol—Body temperature increased—Vincristine—lymphatic system cancer	0.000955	0.00149	CcSEcCtD
Timolol—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000949	0.00149	CcSEcCtD
Timolol—Urticaria—Mitoxantrone—lymphatic system cancer	0.000934	0.00146	CcSEcCtD
Timolol—Hypersensitivity—Carmustine—lymphatic system cancer	0.000932	0.00146	CcSEcCtD
Timolol—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00093	0.00146	CcSEcCtD
Timolol—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00093	0.00146	CcSEcCtD
Timolol—Vomiting—Bleomycin—lymphatic system cancer	0.000922	0.00144	CcSEcCtD
Timolol—Depression—Methotrexate—lymphatic system cancer	0.000916	0.00143	CcSEcCtD
Timolol—Rash—Bleomycin—lymphatic system cancer	0.000914	0.00143	CcSEcCtD
Timolol—Dermatitis—Bleomycin—lymphatic system cancer	0.000913	0.00143	CcSEcCtD
Timolol—Asthenia—Carmustine—lymphatic system cancer	0.000908	0.00142	CcSEcCtD
Timolol—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000893	0.0014	CcSEcCtD
Timolol—Hypersensitivity—Vincristine—lymphatic system cancer	0.00089	0.00139	CcSEcCtD
Timolol—Sweating—Methotrexate—lymphatic system cancer	0.000881	0.00138	CcSEcCtD
Timolol—Epistaxis—Methotrexate—lymphatic system cancer	0.000867	0.00136	CcSEcCtD
Timolol—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000867	0.00136	CcSEcCtD
Timolol—Asthenia—Vincristine—lymphatic system cancer	0.000867	0.00136	CcSEcCtD
Timolol—Diarrhoea—Carmustine—lymphatic system cancer	0.000866	0.00136	CcSEcCtD
Timolol—Nausea—Bleomycin—lymphatic system cancer	0.000861	0.00135	CcSEcCtD
Timolol—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000858	0.00134	CcSEcCtD
Timolol—Asthenia—Mitoxantrone—lymphatic system cancer	0.000844	0.00132	CcSEcCtD
Timolol—Dizziness—Carmustine—lymphatic system cancer	0.000837	0.00131	CcSEcCtD
Timolol—Diarrhoea—Vincristine—lymphatic system cancer	0.000826	0.00129	CcSEcCtD
Timolol—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000805	0.00126	CcSEcCtD
Timolol—Vomiting—Carmustine—lymphatic system cancer	0.000804	0.00126	CcSEcCtD
Timolol—Dizziness—Vincristine—lymphatic system cancer	0.000799	0.00125	CcSEcCtD
Timolol—Rash—Carmustine—lymphatic system cancer	0.000798	0.00125	CcSEcCtD
Timolol—Dermatitis—Carmustine—lymphatic system cancer	0.000797	0.00125	CcSEcCtD
Timolol—Visual impairment—Methotrexate—lymphatic system cancer	0.000795	0.00124	CcSEcCtD
Timolol—Headache—Carmustine—lymphatic system cancer	0.000793	0.00124	CcSEcCtD
Timolol—Eye disorder—Methotrexate—lymphatic system cancer	0.000771	0.00121	CcSEcCtD
Timolol—Tinnitus—Methotrexate—lymphatic system cancer	0.000769	0.0012	CcSEcCtD
Timolol—Vomiting—Vincristine—lymphatic system cancer	0.000768	0.0012	CcSEcCtD
Timolol—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000766	0.0012	CcSEcCtD
Timolol—Rash—Vincristine—lymphatic system cancer	0.000762	0.00119	CcSEcCtD
Timolol—Dermatitis—Vincristine—lymphatic system cancer	0.000761	0.00119	CcSEcCtD
Timolol—Headache—Vincristine—lymphatic system cancer	0.000757	0.00118	CcSEcCtD
Timolol—Nausea—Carmustine—lymphatic system cancer	0.000752	0.00118	CcSEcCtD
Timolol—Angiopathy—Methotrexate—lymphatic system cancer	0.000748	0.00117	CcSEcCtD
Timolol—Vomiting—Mitoxantrone—lymphatic system cancer	0.000748	0.00117	CcSEcCtD
Timolol—Immune system disorder—Methotrexate—lymphatic system cancer	0.000745	0.00117	CcSEcCtD
Timolol—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000743	0.00116	CcSEcCtD
Timolol—Rash—Mitoxantrone—lymphatic system cancer	0.000742	0.00116	CcSEcCtD
Timolol—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000741	0.00116	CcSEcCtD
Timolol—Headache—Mitoxantrone—lymphatic system cancer	0.000737	0.00115	CcSEcCtD
Timolol—Alopecia—Methotrexate—lymphatic system cancer	0.000729	0.00114	CcSEcCtD
Timolol—Mental disorder—Methotrexate—lymphatic system cancer	0.000723	0.00113	CcSEcCtD
Timolol—Erythema—Methotrexate—lymphatic system cancer	0.000718	0.00112	CcSEcCtD
Timolol—Malnutrition—Methotrexate—lymphatic system cancer	0.000718	0.00112	CcSEcCtD
Timolol—Nausea—Vincristine—lymphatic system cancer	0.000717	0.00112	CcSEcCtD
Timolol—Dysgeusia—Methotrexate—lymphatic system cancer	0.000703	0.0011	CcSEcCtD
Timolol—Nausea—Mitoxantrone—lymphatic system cancer	0.000699	0.00109	CcSEcCtD
Timolol—Vision blurred—Methotrexate—lymphatic system cancer	0.000677	0.00106	CcSEcCtD
Timolol—Vertigo—Methotrexate—lymphatic system cancer	0.000645	0.00101	CcSEcCtD
Timolol—Cough—Methotrexate—lymphatic system cancer	0.000627	0.000981	CcSEcCtD
Timolol—Chest pain—Methotrexate—lymphatic system cancer	0.000611	0.000957	CcSEcCtD
Timolol—Arthralgia—Methotrexate—lymphatic system cancer	0.000611	0.000957	CcSEcCtD
Timolol—Myalgia—Methotrexate—lymphatic system cancer	0.000611	0.000957	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000607	0.00095	CcSEcCtD
Timolol—Discomfort—Methotrexate—lymphatic system cancer	0.000604	0.000945	CcSEcCtD
Timolol—Confusional state—Methotrexate—lymphatic system cancer	0.000591	0.000925	CcSEcCtD
Timolol—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000586	0.000917	CcSEcCtD
Timolol—Infection—Methotrexate—lymphatic system cancer	0.000582	0.000911	CcSEcCtD
Timolol—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000575	0.0009	CcSEcCtD
Timolol—Skin disorder—Methotrexate—lymphatic system cancer	0.000569	0.000891	CcSEcCtD
Timolol—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000567	0.000887	CcSEcCtD
Timolol—Anorexia—Methotrexate—lymphatic system cancer	0.000559	0.000874	CcSEcCtD
Timolol—Hypotension—Methotrexate—lymphatic system cancer	0.000548	0.000857	CcSEcCtD
Timolol—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000534	0.000836	CcSEcCtD
Timolol—Insomnia—Methotrexate—lymphatic system cancer	0.00053	0.00083	CcSEcCtD
Timolol—Paraesthesia—Methotrexate—lymphatic system cancer	0.000526	0.000824	CcSEcCtD
Timolol—Dyspnoea—Methotrexate—lymphatic system cancer	0.000522	0.000818	CcSEcCtD
Timolol—Somnolence—Methotrexate—lymphatic system cancer	0.000521	0.000816	CcSEcCtD
Timolol—Dyspepsia—Methotrexate—lymphatic system cancer	0.000516	0.000808	CcSEcCtD
Timolol—Decreased appetite—Methotrexate—lymphatic system cancer	0.000509	0.000797	CcSEcCtD
Timolol—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000506	0.000792	CcSEcCtD
Timolol—Fatigue—Methotrexate—lymphatic system cancer	0.000505	0.000791	CcSEcCtD
Timolol—Pain—Methotrexate—lymphatic system cancer	0.000501	0.000784	CcSEcCtD
Timolol—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000483	0.000756	CcSEcCtD
Timolol—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000479	0.00075	CcSEcCtD
Timolol—Urticaria—Methotrexate—lymphatic system cancer	0.000466	0.000729	CcSEcCtD
Timolol—Abdominal pain—Methotrexate—lymphatic system cancer	0.000463	0.000725	CcSEcCtD
Timolol—Body temperature increased—Methotrexate—lymphatic system cancer	0.000463	0.000725	CcSEcCtD
Timolol—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000432	0.000676	CcSEcCtD
Timolol—Asthenia—Methotrexate—lymphatic system cancer	0.00042	0.000658	CcSEcCtD
Timolol—Pruritus—Methotrexate—lymphatic system cancer	0.000415	0.000649	CcSEcCtD
Timolol—Diarrhoea—Methotrexate—lymphatic system cancer	0.000401	0.000628	CcSEcCtD
Timolol—Dizziness—Methotrexate—lymphatic system cancer	0.000388	0.000607	CcSEcCtD
Timolol—Vomiting—Methotrexate—lymphatic system cancer	0.000373	0.000583	CcSEcCtD
Timolol—Rash—Methotrexate—lymphatic system cancer	0.00037	0.000578	CcSEcCtD
Timolol—Dermatitis—Methotrexate—lymphatic system cancer	0.000369	0.000578	CcSEcCtD
Timolol—Headache—Methotrexate—lymphatic system cancer	0.000367	0.000575	CcSEcCtD
Timolol—Nausea—Methotrexate—lymphatic system cancer	0.000348	0.000545	CcSEcCtD
